Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer (2015)
- Authors:
- USP affiliated authors: MANO, MAX SENNA - FM ; HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.1590/1414-431x20144354
- Subjects: QUIMIOTERAPIA ADJUVANTE; ENSAIO CLÍNICO CONTROLADO RANDOMIZADO; NEOPLASIAS MAMÁRIAS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Brazilian Journal of Medical and Biological Research
- ISSN: 1414-431X
- Volume/Número/Paginação/Ano: v. 48, n. 5, p. 479-485, 2015
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
PETRY, V. et al. Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer. Brazilian Journal of Medical and Biological Research, v. 48, n. 5, p. 479-485, 2015Tradução . . Disponível em: https://doi.org/10.1590/1414-431x20144354. Acesso em: 24 abr. 2024. -
APA
Petry, V., Gagliato, D. M., Leal, A. I. C., Arai, R. J., Longo, E., Andrade, F., et al. (2015). Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer. Brazilian Journal of Medical and Biological Research, 48( 5), 479-485. doi:10.1590/1414-431x20144354 -
NLM
Petry V, Gagliato DM, Leal AIC, Arai RJ, Longo E, Andrade F, Ricci MD, Piato JR, Barroso-Sousa R, Hoff PM, Mano MS. Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer [Internet]. Brazilian Journal of Medical and Biological Research. 2015 ; 48( 5): 479-485.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1590/1414-431x20144354 -
Vancouver
Petry V, Gagliato DM, Leal AIC, Arai RJ, Longo E, Andrade F, Ricci MD, Piato JR, Barroso-Sousa R, Hoff PM, Mano MS. Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer [Internet]. Brazilian Journal of Medical and Biological Research. 2015 ; 48( 5): 479-485.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1590/1414-431x20144354 - Rare tumors research in emerging countries
- Malignancy-related hypercalcemia in the bishosphonate era
- Ascite quilosa em paciente com carcinoma ductal invasivo de mama
- Câncer de mama HER2 positivo: tratamento (NEO) adjuvante - análise das pacientes tratadas no ICESP
- Feasibility of two schedules of weekly paclitaxel in HER2-negative early breast cancer in a Brazilian community setting
- Serum levels of VEGF and MCSF in HER2+/HER2- breast cancer patients with metronomic neoadjuvant chemotherapy
- Carcinoma neuroendócrino primário de mama (CNEM) - um diagnóstico raro: relato de dois casos
- Value of systemic staging in asymptomatic early breast cancer
- Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
- Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1
Informações sobre o DOI: 10.1590/1414-431x20144354 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
